Newsroom

Sorted by: Latest

-

Powerful Medical and corpuls Partner to Bring Queen of Hearts AI-Powered Heart Attack Detection to Prehospital Care

BRATISLAVA, Slovakia--(BUSINESS WIRE)--Powerful Medical, developer of the PMcardio AI cardiology platform, and corpuls, Europe's leading manufacturer of monitor/defibrillator systems for prehospital emergency medical services, today announced a strategic partnership to integrate Powerful Medical's Queen of Hearts AI ECG model directly into the corpuls platform used by emergency care professionals in over 70 countries globally. Health care professionals recording a 12-lead ECG on a corpuls3 devi...
-

LEO Pharma presents new data on delgocitinib cream at EADV 2026 highlighting real-world outcomes in adults and new adolescent data in Chronic Hand Eczema (CHE)

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, has presented new data on delgocitinib cream in Chronic Hand Eczema (CHE) at the 35th European Academy of Dermatology and Venereology (EADV) Congress, held from 30 September to 3 October 2026 in Vienna, Austria. In total, six delgocitinib presentations feature in the company’s programme at the congress, including one oral presentation and five ePosters, spanning adults and adolescents, controlled clinica...
-

Roquette apresentará soluções farmacêuticas de ponta a ponta para formulações centradas no paciente na CPHI Milão 2026

LILLE, França--(BUSINESS WIRE)--A Roquette apresentará seu portfólio completo de excipientes farmacêuticos, soluções de administração de fármacos e expertise técnica de ponta na CPHI Milão 2026 na Itália, onde a empresa receberá visitantes no estande 1A18 no salão de excipientes. No evento global deste ano, a Roquette destacará as principais marcas de produtos que apoiam o desempenho das formulações, a administração de fármacos centrada no paciente e a inovação biofarmacêutica, incluindo os éte...
-

Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced two new clinical experts will join its global medical leadership team, led by Global Chief Medical Officer Pat Carroll, MD. Kultar Garcha, MD, will serve as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, will serve as Chief Medical Officer of Hims Australia. The appointments mark the company’s latest step in streng...
-

Defense Health Agency Selects Hypori to Secure Clinical Dictation on Clinicians' Personal Phones

RESTON, Va.--(BUSINESS WIRE)--Hypori, the leading secure mobile access and virtual mobile infrastructure (VMI) platform, today announced that the Defense Health Agency (DHA) deployed Hypori's VMI platform to give clinicians secure, hands-free access to Oracle Health's ambient clinical dictation technology (Clinical Agent AI) from their own personal phones. The integration ensures personal health information (PHI), controlled unclassified information (CUI), and Department of War (DoW) data are n...
-

Monroe Capital Prices $398.9 Million Private Credit CLO

CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”), a leading private credit asset manager, today announced the successful pricing of Monroe Capital PC CLO II, LP, a $398.9 million collateralized loan obligation (“CLO”) transaction. The transaction represents Monroe’s second new-issue CLO completed in 2026 and its fourth CLO transaction over the past 12 months. The CLO is collateralized primarily by a diversified portfolio of senior secured loans to lower middle-market and traditional midd...
-

Magnolia Oil & Gas Provides Interim Financial and Operations Update After Closing the Acquisition of WildFire Energy

HOUSTON--(BUSINESS WIRE)--Magnolia Oil & Gas Provides Interim Financial and Operations Update...
-

Everlywell Brings Clairity’s FDA-Authorized AI Breast Cancer Risk Assessment to Women Nationwide

AUSTIN, Texas--(BUSINESS WIRE)--Everlywell, the leader in digital health, diagnostics and virtual care, today announced the nationwide launch and commercial availability of Clairity Breast on its consumer platform. Clairity Breast is the first FDA-authorized AI-driven software that can assess a woman's five-year risk of developing breast cancer from a routine screening mammogram. Together with Everlywell's real-world, nationwide reach, the partnership gives women across the U.S. more informatio...
-

Lumentum Announces Speaker Lineup at 2026 OCP Global Summit

SAN JOSE, Calif.--(BUSINESS WIRE)--Lumentum, a global leader in optical and photonic technology, today announced its speaker lineup at the 2026 Open Compute Project (OCP) Global Summit, themed “Scaling Innovation for the AI Era.” The event will take place from October 12 – 15 at the San Jose McEnery Convention Center. External Laser Source Architectures for Deployable CPO-Based AI Networks​ Christian Urricariet, Senior Director, Product and Strategic Marketing Wednesday, October 14 from 1:10 –...
-

ロケット、CPHIミラノ2026にて、患者中心の製剤向けのエンド・ツー・エンドの製薬ソリューションを展示

フランス・リール--(BUSINESS WIRE)--(ビジネスワイヤ) -- ロケットは、イタリアで開催されるCPHIミラノ2026において、医薬品添加物、薬物送達ソリューション、そして業界をリードする技術的専門知識からなるエンド・ツー・エンドのポートフォリオを展示します。同社は、医薬品添加物メーカーが集まるホールのブース1A18にて来場者をお迎えします。 今年のグローバル業界イベントにおいて、ロケットは、製剤性能、患者中心の薬物送達、およびバイオ医薬品のイノベーションを支える主要製品ブランドを重点的に紹介します。これには、METHOCEL™セルロースエーテル、PEARLITOL®マンニトール、Avicel®微結晶セルロース、POLYOX™ポリエチレンオキシド、KLEPTOSE®シクロデキストリン、LYCADEX®パイロジェンフリー・デキストロース・モノハイドレート、Qualicaps™ by Roquetteハードカプセル、および持続可能な方法で調達された海藻由来のアルギン酸ポートフォリオなどです。また、同社は、上流工程、下流工程の効率化、製剤支援にまたがるバイオ医薬品ソリューシ...